MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10

Clin Immunol. 2016 Mar:164:106-13. doi: 10.1016/j.clim.2015.12.009. Epub 2016 Feb 1.

Abstract

MiR-15a is likely to be associated with autoimmunity. Here, we aimed to examine the expression of miR-15 cluster in PBMCs from myasthenia gravis (MG) patients and investigate the potential roles of miR-15a in MG. We found that the expression of all miR-15 cluster was decreased in MG, furthermore, miR-15a levels in ocular MG (oMG) were much lower, while CXCL10 production was increased in MG. We display that CXCL10 was a functional target gene of miR-15a in MG. Increasing miR-15a expression could reduce CXCL10 expression and alleviate the abnormal T cells activation in immune response, while decreasing miR-15a expression could activate immune response abnormally. Moreover, miR-15a expression was significantly decreased after stimulation, and prednisone treatment could upregulate miR-15a expression in steroid-responsive MG patients. Take together, our data suggest that decreased miR-15a expression facilitates proinflammatory cytokines production and contributes to immune response at least in part via regulating CXCL10 expression in MG.

Keywords: CXCL10; Immune response, T cells; Myasthenia gravis; miR-15a.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cells, Cultured
  • Chemokine CXCL10 / genetics
  • Chemokine CXCL10 / immunology*
  • Child
  • Female
  • HEK293 Cells
  • Humans
  • Leukocytes, Mononuclear / immunology
  • Male
  • MicroRNAs / genetics
  • MicroRNAs / immunology*
  • Middle Aged
  • Myasthenia Gravis / genetics
  • Myasthenia Gravis / immunology*
  • Young Adult

Substances

  • CXCL10 protein, human
  • Chemokine CXCL10
  • MIRN15 microRNA, human
  • MicroRNAs